gRNA Market Size, Share, Trends, Growth & Forecast 2026-2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global gRNA Market Size Analysis

Global gRNA Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Synthetic gRNA
  1. By Value
3. In-vitro Transcribed (IVT) gRNA
  1. By Value
4. Plasmid-Encoded gRNA Constructs
  1. By Value
5. RNP Complexes
  1. By Value
6. Multiplex gRNA Libraries
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Genome Editing
  1. By Value
3. Functional Genomics Screens
  1. By Value
4. Disease Model Studies
  1. By Value
5. Cell & Gene Therapy
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Synthetic gRNA
  1. By Value
3. In-vitro Transcribed (IVT) gRNA
  1. By Value
4. Plasmid-Encoded gRNA Constructs
  1. By Value
5. RNP Complexes
  1. By Value
6. Multiplex gRNA Libraries
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Genome Editing
  1. By Value
3. Functional Genomics Screens
  1. By Value
4. Disease Model Studies
  1. By Value
5. Cell & Gene Therapy
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Synthetic gRNA
    1. By Value
  3. In-vitro Transcribed (IVT) gRNA
    1. By Value
  4. Plasmid-Encoded gRNA Constructs
    1. By Value
  5. RNP Complexes
    1. By Value
  6. Multiplex gRNA Libraries
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Genome Editing
    1. By Value
  3. Functional Genomics Screens
    1. By Value
  4. Disease Model Studies
    1. By Value
  5. Cell & Gene Therapy
    1. By Value
  6. Epigenetics
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Synthetic gRNA
  1. By Value
3. In-vitro Transcribed (IVT) gRNA
  1. By Value
4. Plasmid-Encoded gRNA Constructs
  1. By Value
5. RNP Complexes
  1. By Value
6. Multiplex gRNA Libraries
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Genome Editing
  1. By Value
3. Functional Genomics Screens
  1. By Value
4. Disease Model Studies
  1. By Value
5. Cell & Gene Therapy
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Synthetic gRNA
    1. By Value
  3. In-vitro Transcribed (IVT) gRNA
    1. By Value
  4. Plasmid-Encoded gRNA Constructs
    1. By Value
  5. RNP Complexes
    1. By Value
  6. Multiplex gRNA Libraries
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Genome Editing
    1. By Value
  3. Functional Genomics Screens
    1. By Value
  4. Disease Model Studies
    1. By Value
  5. Cell & Gene Therapy
    1. By Value
  6. Epigenetics
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Synthetic gRNA
  1. By Value
3. In-vitro Transcribed (IVT) gRNA
  1. By Value
4. Plasmid-Encoded gRNA Constructs
  1. By Value
5. RNP Complexes
  1. By Value
6. Multiplex gRNA Libraries
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Genome Editing
  1. By Value
3. Functional Genomics Screens
  1. By Value
4. Disease Model Studies
  1. By Value
5. Cell & Gene Therapy
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Synthetic gRNA
    1. By Value
  3. In-vitro Transcribed (IVT) gRNA
    1. By Value
  4. Plasmid-Encoded gRNA Constructs
    1. By Value
  5. RNP Complexes
    1. By Value
  6. Multiplex gRNA Libraries
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Genome Editing
    1. By Value
  3. Functional Genomics Screens
    1. By Value
  4. Disease Model Studies
    1. By Value
  5. Cell & Gene Therapy
    1. By Value
  6. Epigenetics
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Synthetic gRNA
  1. By Value
3. In-vitro Transcribed (IVT) gRNA
  1. By Value
4. Plasmid-Encoded gRNA Constructs
  1. By Value
5. RNP Complexes
  1. By Value
6. Multiplex gRNA Libraries
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Genome Editing
  1. By Value
3. Functional Genomics Screens
  1. By Value
4. Disease Model Studies
  1. By Value
5. Cell & Gene Therapy
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Synthetic gRNA
    1. By Value
  3. In-vitro Transcribed (IVT) gRNA
    1. By Value
  4. Plasmid-Encoded gRNA Constructs
    1. By Value
  5. RNP Complexes
    1. By Value
  6. Multiplex gRNA Libraries
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Genome Editing
    1. By Value
  3. Functional Genomics Screens
    1. By Value
  4. Disease Model Studies
    1. By Value
  5. Cell & Gene Therapy
    1. By Value
  6. Epigenetics
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Synthetic gRNA
  1. By Value
3. In-vitro Transcribed (IVT) gRNA
  1. By Value
4. Plasmid-Encoded gRNA Constructs
  1. By Value
5. RNP Complexes
  1. By Value
6. Multiplex gRNA Libraries
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Genome Editing
  1. By Value
3. Functional Genomics Screens
  1. By Value
4. Disease Model Studies
  1. By Value
5. Cell & Gene Therapy
  1. By Value
6. Epigenetics
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Others
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Synthetic gRNA
    1. By Value
  3. In-vitro Transcribed (IVT) gRNA
    1. By Value
  4. Plasmid-Encoded gRNA Constructs
    1. By Value
  5. RNP Complexes
    1. By Value
  6. Multiplex gRNA Libraries
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Genome Editing
    1. By Value
  3. Functional Genomics Screens
    1. By Value
  4. Disease Model Studies
    1. By Value
  5. Cell & Gene Therapy
    1. By Value
  6. Epigenetics
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

gRNA Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Thermo Fisher Scientific
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Agilent Technologies
Merck KGaA
Synthego
Integrated DNA Technologies (IDT)
GenScript Biotech
PerkinElmer Inc.
System Biosciences
Jena Bioscience
Synbio Technologies
Takara Bio
Oligo Factory
Creative Biolabs
GreenLight Biosciences
GeneCopoeia
OriGene Technologies
Addgene
CRISPR Therapeutics
Editas Medicine
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment